AHCO

AdaptHealth Corp. NASDAQ

Healthcare ·Medical - Devices ·US · adapthealth.com

$13.04

After hrs $11.99 +2.04%

Mkt Cap $1.8B

52w Low $7.95 92.9% of range 52w High $13.43

50d MA $11.22 200d MA $10.01

P/E (TTM) -25.3x

EV/EBITDA 6.2x

P/B 1.2x

Debt/Equity 1.2x

ROE -4.7%

P/FCF 6.1x

RSI (14) —

ATR (14) —

Beta 1.50

50d MA $11.22

200d MA $10.01

Avg Volume 1.4M

About

AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and in…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 24, 2026	BMO	0.34	0.27	-20.6%	8.86	-0.5%	+5.3%	+5.3%	+2.5%	+3.3%	+8.8%	—
Nov 4, 2025	BMO	0.24	0.22	-8.3%	10.67	-0.2%	-3.1%	-3.1%	-9.9%	-11.0%	-11.9%	—
Aug 5, 2025	BMO	0.15	0.01	-93.3%	10.11	-0.1%	-2.6%	-2.6%	-8.2%	-9.1%	-7.7%	—
May 6, 2025	BMO	0.01	0.01	+0.0%	8.85	-0.6%	-6.9%	-6.9%	-5.3%	-3.2%	+2.9%	—
Feb 25, 2025	BMO	0.25	0.39	+56.0%	10.64	+0.0%	+4.3%	+4.3%	+4.2%	+7.0%	+3.4%	—
Nov 5, 2024	BMO	0.17	0.15	-11.8%	9.18	+3.4%	+10.9%	+10.9%	+7.1%	+9.9%	+13.8%	—
Aug 6, 2024	BMO	0.19	0.21	+10.5%	8.66	+1.8%	+4.8%	+4.8%	+9.5%	+8.8%	+8.7%	—
May 7, 2024	BMO	0.06	0.02	-66.7%	9.76	-1.0%	-0.7%	-0.7%	-5.8%	-0.9%	-2.7%	—
Feb 27, 2024	BMO	0.20	0.64	+220.0%	10.00	+2.0%	+2.7%	+2.7%	+2.3%	+5.2%	+5.8%	—
Nov 7, 2023	BMO	0.19	0.19	+0.0%	7.69	-6.0%	-15.5%	-15.5%	-11.4%	-10.5%	-1.4%	—
Aug 8, 2023	BMO	0.11	0.16	+45.5%	14.68	+2.0%	+0.6%	+0.6%	-4.6%	-5.4%	-5.7%	—
May 9, 2023	BMO	0.08	0.01	-87.5%	11.30	-2.0%	-2.1%	-2.1%	-10.7%	-6.2%	-1.7%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 13	Truist	Maintains	Buy → Buy	—	$12.17	$12.26	+0.7%	+1.2%	+4.9%	+3.9%	+3.4%	+4.0%
Feb 26	Leerink Partners	Maintains	Outperform → Outperform	—	$9.33	$9.35	+0.2%	-2.7%	-1.9%	+3.3%	+0.8%	+3.6%
Nov 6	Canaccord Genuity	Maintains	Buy → Buy	—	$10.34	$10.27	-0.7%	-7.1%	-8.1%	-9.1%	-7.7%	-9.9%
May 12	Truist	Maintains	Buy → Buy	—	$8.57	$9.00	+5.0%	+6.3%	+5.4%	+3.9%	+5.5%	+5.3%
May 8	RBC Capital	Maintains	Outperform → Outperform	—	$8.24	$8.28	+0.5%	+1.7%	+4.0%	+10.6%	+9.6%	+8.0%
Feb 27	Baird	Maintains	Outperform → Outperform	—	$11.10	$11.22	+1.1%	-0.1%	+2.5%	-0.9%	-6.8%	-5.9%
Feb 26	Truist	Maintains	Buy → Buy	—	$10.64	$10.64	+0.0%	+4.3%	+4.2%	+7.0%	+3.4%	-2.8%
Feb 26	RBC Capital	Maintains	Outperform → Outperform	—	$10.64	$10.64	+0.0%	+4.3%	+4.2%	+7.0%	+3.4%	-2.8%
Feb 26	Canaccord Genuity	Maintains	Buy → Buy	—	$10.64	$10.64	+0.0%	+4.3%	+4.2%	+7.0%	+3.4%	-2.8%
Feb 13	UBS	Maintains	Buy → Buy	—	$8.95	$8.99	+0.4%	-0.2%	-1.9%	-2.3%	+0.6%	-2.0%
Nov 19	RBC Capital	Maintains	Outperform → Outperform	—	$9.57	$9.33	-2.5%	+1.8%	+1.6%	+3.3%	+3.0%	+5.7%
Nov 15	Truist	Maintains	Buy → Buy	—	$10.04	$10.08	+0.4%	-4.0%	-4.7%	-3.0%	-3.2%	-1.5%
Nov 6	UBS	Maintains	Buy → Buy	—	$9.18	$9.49	+3.4%	+10.9%	+7.1%	+9.9%	+13.8%	+16.4%
Nov 6	Canaccord Genuity	Maintains	Buy → Buy	—	$9.18	$9.49	+3.4%	+10.9%	+7.1%	+9.9%	+13.8%	+16.4%
Nov 6	Baird	Maintains	Outperform → Outperform	—	$9.18	$9.49	+3.4%	+10.9%	+7.1%	+9.9%	+13.8%	+16.4%
Aug 12	RBC Capital	Maintains	Outperform → Outperform	—	$9.42	$9.47	+0.5%	-0.1%	+3.0%	+3.4%	+8.6%	+11.0%
May 15	Truist	Maintains	Buy → Buy	—	$9.83	$10.02	+1.9%	+0.1%	+0.2%	+1.5%	+0.6%	-0.7%
Mar 4	RBC Capital	Maintains	Outperform → Outperform	—	$10.52	$10.66	+1.3%	+0.6%	-1.4%	-0.4%	+4.2%	+3.1%
Feb 28	UBS	Maintains	Buy → Buy	—	$10.00	$10.20	+2.0%	+2.7%	+2.3%	+5.2%	+5.8%	+3.7%
Feb 28	Truist	Maintains	Buy → Buy	—	$10.00	$10.20	+2.0%	+2.7%	+2.3%	+5.2%	+5.8%	+3.7%
Jan 29	UBS	Maintains	Buy → Buy	—	$7.09	$7.02	-1.0%	+3.8%	+2.4%	+1.8%	+3.2%	+5.4%
Nov 8	BofA Securities	Downgrade	Neutral → Underperform	—	$7.69	$7.23	-6.0%	-15.5%	-11.4%	-10.5%	-1.4%	+9.9%
Nov 8	Truist	Maintains	Buy → Buy	—	$7.69	$7.23	-6.0%	-15.5%	-11.4%	-10.5%	-1.4%	+9.9%
Nov 8	RBC Capital	Maintains	Outperform → Outperform	—	$7.69	$7.23	-6.0%	-15.5%	-11.4%	-10.5%	-1.4%	+9.9%
Oct 11	Truist	Maintains	Buy → Buy	—	$8.41	$8.22	-2.3%	-10.4%	-10.7%	-11.5%	-14.4%	-10.7%
Sep 22	BofA Securities	Maintains	Neutral → Neutral	—	$8.66	$8.61	-0.6%	-0.7%	+1.6%	+1.0%	+1.4%	+2.1%
Jul 13	Baird	Maintains	Outperform → Outperform	—	$12.74	$13.03	+2.3%	+0.5%	+4.9%	+5.8%	+13.4%	+12.6%
Jun 28	Baird	Maintains	Outperform → Outperform	—	$11.28	$11.27	-0.1%	+2.9%	+6.1%	+7.9%	+6.2%	+5.9%
Jun 27	Baird	Maintains	Outperform → Outperform	—	$9.43	$9.41	-0.2%	+19.6%	+23.1%	+26.9%	+29.1%	+27.0%
May 11	RBC Capital	Maintains	Outperform → Outperform	—	$11.06	$10.99	-0.6%	-8.8%	-4.2%	+0.5%	+0.3%	+1.4%
May 10	Baird	Maintains	Outperform → Outperform	—	$11.30	$11.07	-2.0%	-2.1%	-10.7%	-6.2%	-1.7%	-1.9%
May 10	Deutsche Bank	Downgrade	Buy → Hold	—	$11.30	$11.07	-2.0%	-2.1%	-10.7%	-6.2%	-1.7%	-1.9%
May 10	Truist	Maintains	Buy → Buy	—	$11.30	$11.07	-2.0%	-2.1%	-10.7%	-6.2%	-1.7%	-1.9%
May 10	Canaccord Genuity	Maintains	Buy → Buy	—	$11.30	$11.07	-2.0%	-2.1%	-10.7%	-6.2%	-1.7%	-1.9%
May 10	Stifel	Downgrade	Buy → Hold	—	$11.30	$11.07	-2.0%	-2.1%	-10.7%	-6.2%	-1.7%	-1.9%
May 9	BofA Securities	Downgrade	Buy → Neutral	—	$12.07	$10.86	-10.0%	-6.4%	-8.4%	-16.4%	-12.2%	-8.0%
Apr 13	Truist	Maintains	Buy → Buy	—	$12.08	$12.14	+0.5%	+0.7%	-1.1%	-2.6%	-3.6%	-1.5%
Mar 1	Baird	Maintains	Outperform → Outperform	—	$15.99	$15.95	-0.3%	-5.4%	-3.1%	+0.1%	-6.5%	-5.8%
Nov 10	SVB Leerink	Maintains	Outperform → Outperform	—	$20.72	$21.79	+5.2%	+9.1%	+10.2%	+5.8%	+5.9%	+3.8%
Sep 20	Deutsche Bank	Maintains	Buy → Buy	—	$22.12	$22.35	+1.0%	-1.9%	-7.9%	-9.6%	-13.1%	-12.8%
Sep 19	Truist	Maintains	Buy → Buy	—	$20.15	$20.51	+1.8%	+9.8%	+7.7%	+1.1%	-0.8%	-4.6%
Aug 10	RBC Capital	Maintains	Outperform → Outperform	—	$22.24	$21.84	-1.8%	+5.3%	+4.3%	+6.2%	+4.3%	-1.0%
Aug 10	SVB Leerink	Maintains	Outperform → Outperform	—	$22.24	$21.84	-1.8%	+5.3%	+4.3%	+6.2%	+4.3%	-1.0%
Jul 14	Truist	Maintains	Buy → Buy	—	$19.44	$19.56	+0.6%	+0.9%	+3.6%	+4.3%	+4.3%	+7.2%
Mar 8	RBC Capital	Maintains	Outperform → Outperform	—	$15.54	$15.44	-0.6%	+7.4%	+7.4%	+4.6%	-0.2%	-1.3%
Mar 2	SVB Leerink	Maintains	Outperform → Outperform	—	$15.92	$15.94	+0.1%	-4.0%	-5.8%	-5.2%	-2.4%	+4.8%
Feb 18	SVB Leerink	Maintains	Outperform → Outperform	—	$17.43	$17.50	+0.4%	-3.8%	-9.8%	-10.7%	-12.9%	-7.1%
Nov 5	SVB Leerink	Maintains	Outperform → Outperform	—	$25.85	$26.17	+1.2%	-3.5%	-0.8%	-5.4%	-2.4%	-3.3%
Sep 27	SVB Leerink	Maintains	Outperform → Outperform	—	$23.00	$23.23	+1.0%	+3.3%	+1.7%	+1.1%	+1.3%	+2.5%
Jul 14	Baird	Upgrade	Neutral → Outperform	—	$26.27	$26.83	+2.1%	-2.6%	-1.9%	-3.0%	-8.8%	-13.0%

Recent Filings

8-K · 5.02 !!! Very High

AdaptHealth Corp. -- 8-K 5.02: Executive Change

AdaptHealth Corp. appointed Daniel McFadden as Chief Operating Officer while director Toby Scott Barnhart resigned, signaling potential management restructuring that investors should monitor for strategic implications.

May 5

8-K · 1.01 ! Medium

Unknown — 8-K 1.01: Financing / Debt Agreement

BAC and AHCO's new debt agreement likely increases borrowing capacity and financial flexibility, which could support growth initiatives or improve balance sheet strength, benefiting shareholders if capital deployment is effective.

Apr 13

8-K

AdaptHealth Corp. -- 8-K Filing

AdaptHealth reported fourth-quarter and full-year 2025 financial results as a leading home healthcare provider offering medical equipment, supplies, and related services.

Feb 24

Data updated apr 24, 2026 4:42pm · Source: massive.com